FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
Company Profile for Pacific Legal Foundation
An examination of 10 CEFs with the highest duration risk.
We take a look at 2012's municipal CEF performance, distribution cuts, mergers, and more.
Population Bio Recognizes World Rare Disease Day 2017 with a Commitment to Provide New Insights into Rare Diseases